Welcome to the Chandler Grant Glaucoma SocietyA Message from the PresidentWelcome to the Chandler Grant Glaucoma Society website. Since the Society was founded in 1982, its members have worked to carry on the ethical and moral values of our namesakes, Dr. Paul Chandler and Dr. W. Morton Grant. A key focus of our members is the continuing effort to prevent blindness from glaucoma through innovative research, development of clinical applications of scientific knowledge, and raising public awareness of glaucoma. Initial members of the Society were fellows who trained directly under Drs. Chandler and Grant. Current (and future) members include ophthalmologists in subsequent generations of Chandler and Grant fellows which fosters our ability to carry on the principles started by these two remarkable physicians. For those trained under the lineage of Drs. Chandler or Grant, we invite you to JOIN US! Sincerely, Joshua D. Stein, MD, MS Joshua D. Stein, MD, MS | President |
March 1st Highlights! Hyatt Regency Huntington Beach | CA Over 60 members gathered on March 1st for our annual meeting. The evening commenced with a reception, followed by welcoming remarks from President Joshua Stein, MD, MS. Dr. Joel Schuman moderated the "Glass of Wine with Chandler and Grant," during which all attendees raised their glasses in a toast to honor the legacies of Drs. Chandler and Grant. Read more. Featured in the photos to the right: (Top left) CGGS members Steven Sarkisian, MD and Eric Brown, MD. (Top right) Presenter and Past President Cindie Mattox, MD; President-Elect Peter Netland, MD; Immediate Past President Janey Wiggs, MD, PhD. (Bottom) CGGS Officers and Alcon Team members. |
IN THE NEWS |
ALCON (formerly Aerie Pharmaceuticals) COMMITS TO FIVE-YEAR GRANT TO FUND AWARD The Chandler Grant Glaucoma Society (CGGS) is pleased to announce an exclusive five-year partnership with Aerie Pharmaceuticals, Inc., to fund the distinguished David L. Epstein Clinician-Scientist Research Award. The CGGS created this award to honor Dr. Epstein, who is widely \considered to be one of the most influential leaders in the world of glaucoma and glaucoma research over the past 40 years. The award is a small way to honor his commitment to the scientific understanding and cure of glaucoma through the support of promising clinician-scientists in research environments. As Joel Schuman, MD, past-president, CGGS, once wrote in a tribute to Dr. Epstein, his “greatest legacy is the army of clinician-scientists whom he inspired throughout his years.” |
Learn About GlaucomaGlaucoma is an eye disease that has been called the "sneak thief of sight" because permanent damage to the eye can occur before patient even notices symptoms. That is why early detection and management of this chronic disease is so important. Information from the American Glaucoma Society - click here |
THANK YOU TO ALCON FOR THEIR COMMITMENT TO SUPPORT THE DAVID L. EPSTEIN CLINICIAN-SCIENTIST RESEARCH AWARD |